Development of naftifine hydrochloride alcohol-free niosome gel

Drug Development and Industrial Pharmacy

Volumn 35, Issue 5, 2009, Pages 631-637

  Barakat, Heba S ^a   Darwish, Inas A ^a   El Khordagui, Labiba K ^a   Khalafallah, Nawal M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Alcohol free; Gels; Naftifine hydrochloride; Niosomes

Indexed keywords

HYDROXYETHYLCELLULOSE; NAFTIFINE HYDROCHLORIDE ALCOHOL FREE NIOSOME GEL; NIOSOME; UNCLASSIFIED DRUG; ALLYLAMINE; ANTIFUNGAL AGENT; CELLULOSE; DICETYL PHOSPHATE; DRUG DERIVATIVE; EXCIPIENT; LIPOSOME; NAFTIFINE; ORGANOPHOSPHATE; POLYSORBATE;

ARTICLE; CONTROLLED STUDY; DRUG CONCENTRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; PATIENT COMPLIANCE; SCANNING ELECTRON MICROSCOPE; CHEMISTRY; GEL; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY;

ALLYLAMINE; ANTIFUNGAL AGENTS; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; EXCIPIENTS; GELS; LIPOSOMES; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; PHOSPHORIC ACID ESTERS; POLYSORBATES; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 67049138428     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802498864     Document Type: Article

References (23)

1. Aggarwal, D., Garg, A., & Kaur, I. P. (2004). Development of a topical niosomal preparation of acetazolamide: Preparation and evaluation. J. Pharm. Pharmacol., 56(12), 1509-1517
2. Bacchi-Modena, A., Bolis, P., Campagnoli, C., & De Cicco, F. (1997). Efficacy and tolerability of estraderm MX® , a new estradiol matrix patch. Maturitas, 27(3), 285-292
3. Baumanna, M. A., Rath, B., Fischer, J. H., & Iffland, R. (2000). The permeability of dental procedure and examination gloves by an alcohol based disinfectant. Dent. Mater., 16(2), 139-144
4. Carafa, M., Marianecci, C., Lucania, G., Marchei, E., & Santucci, E. (2004). New vesicular ampicillin-loaded delivery systems for topical application: Characterization, in vitro permeation experiments and antimicrobial activity. J. Control. Release, 95(1), 67-74
5. Carafa, M., Santucci, E., Alhaique, F., Coviello, T., Murtas, E., Riccieri, F. M., Lucania, G., & Torrisi, M. R. (1998). Preparation and properties of new unilamellar non-ionic surfactant vesicles. Int. J. Pharm., 160(1), 51-59
6. Desai, T. R., & Finlay, W. H. (2002). Nebulization of niosomal all-transretinoic acid: An inexpensive alternative to conventional liposomes. Int. J. Pharm., 241(2), 311-317
7. Girigoswami, A., Das, S., & De, S. (2006). Fluorescence and dynamic light scattering studies of niosomes-membrane mimetic systems. Spectrochim. Acta A Mol. Biomol. Spectrosc., 64(4), 860-866
8. Glavas-Dodov, M., Fredro-Kumbaradzi, E., Goracinova, K., Calis, S., & Hincal, A. A. (2003). 5-Fluorouracil in topical liposome gels for anticancer treatment-formulation and evaluation. Acta Pharm., 53(4), 241-250
9. Hao, Y., Zhao, F., Li, N., Yang, Y., & Li, K. (2002). Studies on a high encapsulation of colchicine by a niosome system. Int. J. Pharm., 244(1-2), 73-80
10. Hess, J., Molinari, J. A., Gleason, M. J., & Radecki, C. (1991). Epidermal toxicity of disinfectants. Am. J. Dent., 4(1), 51-56
11. Jain, S., Singh, P., Vyas, S. P., & Mishra, V. (2005). Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol. Lett., 101(1), 41-49 (Pubitemid 41297497)
12. Manosroi, A., Wongtrakul, P., Manosroi, J., Sakai, H., Yuasa, M., Sugawara, F., & Abe, M. (2003). Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf. B Biointerf., 30(1), 129-138
13. MerzPharmaceuticals. (2004). Naftifine hydrochloride 1% gel, Retrieved June 17, 2008, from http://www.merzusa.com/pdfs/naftin%20gel%20PI%204-04b.pdf
14. Narang, A. S., Delmarre, D., & Gaoc, D. (2007). Stable drug encapsulation in micelles and microemulsions. Int. J. Pharm., 345(1-2), 9-25
15. Ning, M., Guo, Y., Pan, H., Chen, X., & Gu, Z. (2005). Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Dev. Ind. Pharm., 31(4-5), 375-383 (Pubitemid 41289150)
16. Scheuplein, R., & Ross, L. (1970). Effects of surfactants and solvents on the permeability of epidermis. J. Soc. Cosmet. Chem., 21, 853-873
17. Shahiwala, A., Misra, A., & Gujarat, I. (2002). Studies in topical application of niosomally entrapped Nimesulide. J. Pharm. Pharmaceut. Sci., 5(3), 220-225
18. Tornier, C., Rosdy, M., & Maibach, H. I. (2006). In vitro skin irritation testing on reconstituted human epidermis: Reproducibility for 50 chemicals tested with two protocols. Toxicol. In Vitro, 20(4), 401-416
19. Turker, S., Erdogan, S., Ozer, A. Y., Ergun, E. L., & Tuncel, M. (2005). Scintigraphic imaging of radiolabelled drug delivery systems in rabbits with arthritis. Int. J. Pharm., 296(1-2), 34-43
20. Uchegbu, I. F., & Vyas, S. P. (1998). Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm., 172(1), 33-70
21. Van Hal, D. A., Bouwstra, J. A., & Junginger, H. E. (1996a). Nonionic surfactant vesicles containing estradiol for topical application. In S. Benita (Ed.), Microencapsulation: Methods and industrial applications (pp. 329-347). New York: Marcel Dekker, Inc
22. Van Hal, D. A., Jeremiasse, J., Vringer, T., Junginger, H. E., & Bouwstra, J. A. (1996b). Encapsulation of lidocaine base and hydrochloride into non-ionic surfactant vesicles (NSVs) and diffusion through human stratum corneum in vitro. Eur. J. Pharm. Sci., 4(1), 147-157
23. Zeljka, P., & Natasa, S. (2004). Liposomal gel with chloramphenicol: Characterisation and in vitro release. Acta Pharm., 54, 319-330